These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 21371603

  • 1. Electron density guided fragment-based drug design--a lead generation example.
    Abad MC, Gibbs AC, Zhang X.
    Methods Enzymol; 2011; 493():487-508. PubMed ID: 21371603
    [Abstract] [Full Text] [Related]

  • 2. Electron density guided fragment-based lead discovery of ketohexokinase inhibitors.
    Gibbs AC, Abad MC, Zhang X, Tounge BA, Lewandowski FA, Struble GT, Sun W, Sui Z, Kuo LC.
    J Med Chem; 2010 Nov 25; 53(22):7979-91. PubMed ID: 21033679
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lead generation and examples opinion regarding how to follow up hits.
    Orita M, Ohno K, Warizaya M, Amano Y, Niimi T.
    Methods Enzymol; 2011 Nov 25; 493():383-419. PubMed ID: 21371599
    [Abstract] [Full Text] [Related]

  • 7. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
    Wyss DF, Wang YS, Eaton HL, Strickland C, Voigt JH, Zhu Z, Stamford AW.
    Top Curr Chem; 2012 Nov 25; 317():83-114. PubMed ID: 21647837
    [Abstract] [Full Text] [Related]

  • 8. Fragment-based drug design.
    Feyfant E, Cross JB, Paris K, Tsao DH.
    Methods Mol Biol; 2011 Nov 25; 685():241-52. PubMed ID: 20981527
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
    Fukunishi Y, Mashimo T, Orita M, Ohno K, Nakamura H.
    J Chem Inf Model; 2009 Apr 25; 49(4):925-33. PubMed ID: 19354203
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology.
    Böttcher J, Jestel A, Kiefersauer R, Krapp S, Nagel S, Steinbacher S, Steuber H.
    Methods Enzymol; 2011 Apr 25; 493():61-89. PubMed ID: 21371587
    [Abstract] [Full Text] [Related]

  • 17. Two 'Golden Ratio' indices in fragment-based drug discovery.
    Orita M, Ohno K, Niimi T.
    Drug Discov Today; 2009 Mar 25; 14(5-6):321-8. PubMed ID: 19028598
    [Abstract] [Full Text] [Related]

  • 18. Fragment screening purely with protein crystallography.
    Spurlino JC.
    Methods Enzymol; 2011 Mar 25; 493():321-56. PubMed ID: 21371597
    [Abstract] [Full Text] [Related]

  • 19. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance.
    Giannetti AM.
    Methods Enzymol; 2011 Mar 25; 493():169-218. PubMed ID: 21371592
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.